GW0742
SIGMA/G3295 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 317318-84-6
Empirical Formula (Hill Notation): C21H17F4NO3S2
Molecular Weight: 471.49
MDL Number: MFCD07369423
Linear Formula: C21H17F4NO3S2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C21H17F4NO3S2/c1-11-7- |
| InChI key | HWVNEWGKWRGSRK-UHFFFAOYSA |
| mp | 134.5-135.5 °C |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | Cc1cc(SCc2sc(nc2C)-c3ccc( |
| solubility | DMSO: >5 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | GW0742 is a highly selective PPARδ agonist. |
| Biochem/physiol Actions: | GW0742 is a highly selective PPARδ agonist. EC50 = 1 nM vs 1 μM and 2 μM for PPARα and PPARγ, respectively. |
| Features and Benefits: | This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Legal Information: | Sold for research purposes under agreement from GlaxoSmithKline |
| Packaging: | 1, 5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| mp | 134.5-135.5 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

